The company’s US operation, which is currently unprofitable, is projected to turn around within the next two to three years.
India's Torrent Pharmaceuticals reported a smaller-than-expected third-quarter profit on Friday, hurt by the planned closure of its insulin manufacturing facility. India's Torrent Pharma misses Q3 ...